Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-10 11:03 am Purchase |
2020-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
The Vanguard Group | 2,828,955 8.570% |
532,517 (+23.19%) |
Filing History |
| 2021-02-08 10:25 am Sale |
2021-02-05 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
FMR CORP | 3,726,914 11.218% |
-1,192,202 (-24.24%) |
Filing History |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
BLACKROCK INC BLK |
2,498,408 7.600% |
183,940 (+7.95%) |
Filing History |
| 2021-01-13 09:32 am Purchase |
2020-12-31 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
First Trust Portfolios L.P. | 1,975,601 5.990% |
1,975,601 (New Position) |
Filing History |
| 2020-08-31 4:30 pm Sale |
2020-08-17 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
Genextra S.p.A. | 4,031,994 12.200% |
-1,500,000 (-27.11%) |
Filing History |
| 2020-05-15 5:24 pm Sale |
2020-05-13 | 13G | Intercept Pharmaceuticals, Inc. ICPT |
Genextra S.p.A. | 5,531,994 16.800% |
-591,834 (-9.66%) |
Filing History |